Trikafta 50 mg / 25 mg / 37.5 mg, 75 mg, Filmtabletten

7680677730023 CH-67773 Filmtabletten
Trikafta 50 mg / 25 mg / 37.5 mg, 75 mg, Filmtabletten
Trikafta 50 mg / 25 mg / 37.5 mg, 75 mg, Filmtabletten
Trikafta 50 mg / 25 mg / 37.5 mg, 75 mg, Filmtabletten
1 / 3
google

Article details

Package size
84 (4 x 21)
Selling units
1764
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/08/2026
Patient information leaflet
Français
21/08/2026
Patient information leaflet
Italien
21/08/2026
Summary of Product Characteristics
Allemand
21/08/2026
Summary of Product Characteristics
Français
21/08/2026
Summary of Product Characteristics
Italien
21/08/2026

Detailed composition

Substance Quantity Type Category
elexacaftorum
50.0 MG Substance Wirkstoff (Principe actif)
ivacaftorum
75.0 MG Substance Wirkstoff (Principe actif)
tezacaftorum
25.0 MG Substance Wirkstoff (Principe actif)
hypromellosi acetas succinas
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ivacaftorum
37.5 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
hypromellosum
- Substance HNIDK
hypromellosi acetas succinas
- Substance HNIDK
lactosum monohydricum
83.6 MG Substance HBESI
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
carmellosum natricum conexum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
hydroxypropylcellulosum
- Substance HNIDK
macrogolum 3350
- Substance HNIDK
E 171
- Substance FNIDK
talcum
- Substance HNIDK
talcum
- Substance HNIDK
E 132
- Substance FIMDK
E 172 (flavum)
- Substance FTODK
cera carnauba
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
natrium
1.34 MG Substance HBESI
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ammonii hydroxidum
- Substance HNIDK
natrium
0.9 MG Substance HBESI

Reimbursement information

Public price
CHF 14565.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2022

Authorization holder

Vertex Pharmaceuticals (CH) GmbH

6300 Zug

Authorization information

Swissmedic authorization number
67773
Drug name
Trikafta, Filmtabletten
Galenic form
TAB
ATC Code
R07AX32
Authorization status
Z
Dispensing category
A
First authorization
10/12/2020
Authorization expiration date
31/12/9999
IT Number
03.99.0.
Domain
Human medicine
Field of application
Mukoviszidose

Package details

Description (FR)
TRIKAFTA 50mg/25mg/37.5mg + 75mg cpr pell 84 pce
Description (DE)
TRIKAFTA 50mg/25mg/37.5mg + 75mg Filmtabl 84 Stk
Market launch
05/01/2022
Narcotic (BTM)
No

Other package sizes (1)

TRIKAFTA 100mg/50mg/75mg + 150mg cpr pell 84 pce
84 (4 x 21) TABL
GTIN: 7680677730016
View
Buy us a coffee Explore the data